#62 Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
If you are buying hemp-derived CBD or delta-8 products at a gas station or retail store in Wisconsin, there is currently no reliable guarantee that what is on the label matches what is in the product, including the THC content.
Hemp-derived products sold legally in retail settings are not subject to the same testing and labeling requirements as products sold through licensed cannabis dispensaries, creating a significant gap in consumer protection. When products contain more THC than disclosed or permitted, consumers have no reliable way to know what they are actually ingesting, which raises meaningful concerns about unintended intoxication, drug interactions, and impaired driving. Standardized third-party testing, accurate labeling, and enforceable potency limits are foundational to safe access, regardless of whether a product is sold as hemp or cannabis.
“Selling unregulated psychoactive products next to the beef jerky and calling it a wellness decision is not a hemp industry, it is a liability waiting to happen to unsuspecting consumers.”
💊 This Milwaukee Journal Sentinel investigation highlights a critical gap in cannabis product quality control. More than half of tested hemp products exceeded legal THC limits, underscoring how unregulated markets create significant risks for consumers who may unknowingly exceed safe or legal thresholds. From a clinical perspective, inconsistent product labeling and potency can complicate treatment monitoring and increase adverse event risk, particularly for patients new to cannabis medicine. Robust third-party testing requirements and state oversight are essential to ensure patients can trust the products they’re using and clinicians can make informed recommendations based on accurate cannabinoid profiles.
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it: